Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-25-020250
Filing Date
2025-10-30
Accepted
2025-10-30 16:42:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 12662
  Complete submission text file 0001493152-25-020250.txt   14294
Mailing Address 4400 BISCAYNE BLVD MIAMI FL 33137-3227
Business Address
FROST PHILLIP MD ET AL (Filed by) CIK: 0000898860 (see all company filings)

Type: SCHEDULE 13D/A

Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Subject) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-87608 | Film No.: 251436574
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)